SMAD4 immunohistochemistry reflects genetic status in juvenile polyposis syndrome
Danielle Langeveld1, W Arnout van Hattem, Wendy W J de Leng
1Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Purpose:
Juvenile polyposis syndrome (JPS) can be caused by a germline defect of the SMAD4 gene. Somatic inactivation of SMAD4 occurs in pancreatic and colorectal cancers and is reflected by loss of SMAD4 immunohistochemistry. Here, SMAD4 immunohistochemistry as a marker of SMAD4 gene status and the role of SMAD4 in the adenoma-carcinoma sequence in neoplastic progression in JPS are studied.
Experimental Design:
Twenty polyps with a SMAD4 germline defect and 38 control polyps were studied by SMAD4 immunohistochemistry. Inactivation of the SMAD4 wild-type allele was studied in dysplastic epithelium and in areas with aberrant SMAD4 expression. APC, beta-catenin, p53, and K-ras were studied to evaluate the adenoma-carcinoma sequence.
Results:
Nine of 20 polyps with a SMAD4 germline defect showed loss of epithelial SMAD4 expression. Loss of heterozygosity of SMAD4 was found in five polyps and a somatic stop codon mutation was found in two polyps without loss of heterozygosity. Remarkably, somatic inactivation of epithelial SMAD4 did not always coincide with dysplasia and aberrant p53 staining was found in four of six dysplastic polyps with normal SMAD4 staining. One K-ras mutation was found in nine juvenile polyps with dysplasia. No evidence for Wnt activation was found.
Conclusions:
SMAD4 immunohistochemistry mirrors genetic status and provides a specific adjunct in the molecular diagnosis of JPS. However, epithelial SMAD4 inactivation is not required for polyp formation and is not obligatory for neoplastic progression in JPS. Instead, different routes to neoplasia in JPS caused by germline SMAD4 mutation seem to be operative, including somatic loss of SMAD4 and p53 inactivation without somatic loss of SMAD4.
Insights
Juvenile polyposis syndrome (JPS) linked to SMAD4 gene defects shows SMAD4 immunohistochemistry reflects genetic status. However, SMAD4 inactivation isn't essential for JPS polyp formation or progression, indicating alternative neoplastic pathways.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Juvenile polyposis syndrome (JPS) is a rare inherited disorder characterized by the development of numerous polyps in the gastrointestinal tract.
- Germline mutations in the SMAD4 gene are a known cause of JPS, and somatic inactivation of SMAD4 is observed in various cancers, including pancreatic and colorectal types.
- SMAD4 immunohistochemistry is used to detect SMAD4 protein loss, reflecting gene status in cancerous tissues.
Purpose of the Study:
- To investigate SMAD4 immunohistochemistry as a marker for SMAD4 gene status in JPS polyps.
- To elucidate the role of SMAD4 in the adenoma-carcinoma sequence during neoplastic progression in JPS.
Main Methods:
- SMAD4 immunohistochemistry was performed on 20 polyps from patients with a SMAD4 germline defect and 38 control polyps.
- Analysis included assessment of SMAD4 wild-type allele inactivation in dysplastic epithelium and areas with aberrant SMAD4 expression.
- Other genes, including APC, beta-catenin, p53, and K-ras, were analyzed to understand the adenoma-carcinoma sequence.
Main Results:
- Loss of epithelial SMAD4 expression was observed in 9 of 20 JPS polyps with a SMAD4 germline defect.
- SMAD4 loss of heterozygosity or somatic stop codon mutations were identified in some polyps.
- Aberrant p53 staining was found in dysplastic polyps even with normal SMAD4 staining, suggesting alternative pathways to neoplasia.
Conclusions:
- SMAD4 immunohistochemistry accurately reflects the genetic status of SMAD4 and aids in the molecular diagnosis of JPS.
- Epithelial SMAD4 inactivation is not a prerequisite for polyp formation or neoplastic progression in JPS.
- Neoplastic progression in JPS may involve distinct pathways, including somatic SMAD4 loss or p53 inactivation independent of SMAD4 status.
More Related Videos
05:45Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
Published on: April 26, 2019
09:35Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches
Published on: April 20, 2021
Related Concept Videos
01:33Pleiotropy
02:23Abnormal Proliferation